CME/CE

Episodes 129-141 of 141

• 

  RestartResume

  Hypertrophic cardiomyopathy: What are the concerns?

  RestartResume

  Hypertrophic cardiomyopathy: What are the concerns?

  MinuteCE®

  Hypertrophic cardiomyopathy: What are the concerns?

  1.00 program credit

  • 

    

    Antonis Pantazis, MD

  1.00 program credit

• 

  RestartResume

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  RestartResume

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  MinuteCE®

  The benefits of icosapent ethyl in addressing residual risk: What is the evidence?

  1.00 program credit

  • 

    

    Lale Tokgözoğlu, MD

  1.00 program credit

• 

  MinuteCE®

  New paradigms in the prevention of ASCVD: The role of EPA and triglycerides

  1.00 credit 3 episodes

  • 

    

    Richard Hobbs, MD

  • 

    

    Lale Tokgözoğlu, MD

  • 

    

    Victor Aboyans, MD, PhD

  1.00 credit 3 episodes

• 

  RestartResume

  Reassessing the role of triglycerides in residual cardiovascular risk

  RestartResume

  Reassessing the role of triglycerides in residual cardiovascular risk

  MinuteCE®

  Reassessing the role of triglycerides in residual cardiovascular risk

  1.00 program credit

  • 

    

    Richard Hobbs, MD

  1.00 program credit

• 

  RestartResume

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  RestartResume

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  MinuteCE®

  Integrating icosapent ethyl in preventive strategies: Practical guidance

  1.00 program credit

  • 

    

    Victor Aboyans, MD, PhD

  1.00 program credit

• 

  RestartResume

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  RestartResume

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  MinuteCE®

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  1.00 program credit

  • 

    

    Shelley Zieroth, MD

  1.00 program credit

• 

  MinuteCE®

  Breaking barriers in guideline-based RAASi therapy: Solving issues with hyperkalemia

  1.00 credit 3 episodes

  • 

    

    Shelley Zieroth, MD

  • 

    

    Mikhail Kosiborod, MD

  • 

    

    Aaron Wong, MD

  1.00 credit 3 episodes

• 

  RestartResume

  What to do if potassium levels increase in HF?

  RestartResume

  What to do if potassium levels increase in HF?

  MinuteCE®

  What to do if potassium levels increase in HF?

  1.00 program credit

  • 

    

    Mikhail Kosiborod, MD

  1.00 program credit

• 

  RestartResume

  Practical experience and model for optimizing RAASi-based therapy in HF

  RestartResume

  Practical experience and model for optimizing RAASi-based therapy in HF

  MinuteCE®

  Practical experience and model for optimizing RAASi-based therapy in HF

  1.00 program credit

  • 

    

    Aaron Wong, MD

  1.00 program credit

• 

  MinuteCE®

  Hypertrophic cardiomyopathy & heart failure: exploring new options

  1.00 credit 3 episodes

  • 

    

    Rudolf de Boer, MD, PhD

  • 

    

    Mariana Brandão, MD

  • 

    

    Iacopo Olivotto, MD

  1.00 credit 3 episodes

• 

  RestartResume

  HCM and heart failure: is your patient at risk?

  RestartResume

  HCM and heart failure: is your patient at risk?

  MinuteCE®

  HCM and heart failure: is your patient at risk?

  1.00 program credit

  • 

    

    Rudolf de Boer, MD, PhD

  1.00 program credit

• 

  RestartResume

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  RestartResume

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  MinuteCE®

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  1.00 program credit

  • 

    

    Iacopo Olivotto, MD

  1.00 program credit

• 

  RestartResume

  Recognizing HCM and HF: making the diagnosis

  RestartResume

  Recognizing HCM and HF: making the diagnosis

  MinuteCE®

  Recognizing HCM and HF: making the diagnosis

  1.00 program credit

  • 

    

    Mariana Brandão, MD

  1.00 program credit